Related Experiment Videos
Genome medicine: gene therapy for the millennium, 30 September-3 October 2001, Rome, Italy.
D C Gruenert1, G Novelli, B Dallapiccola
1Human Molecular Genetics, Department of Medicine, University of Vermont, Burlington, VT 05405, USA.
Gene Therapy
|May 29, 2002
Summary
Advances in DNA sequencing and the Human Genome Project are driving new genetic therapies for inherited disorders. This meeting explored gene evaluation, novel therapeutic strategies, and ethical considerations for genome medicine.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- The Human Genome Project has generated vast DNA sequence data.
- This data fuels technological advancements for identifying disease-associated genes.
- Opportunities for novel genetic therapies for inherited disorders have emerged.
Purpose of the Study:
- To discuss scientific and clinical advances in genome medicine.
- To explore the implications of sequence information for gene therapy.
- To address ethical and social considerations of genetic advancements.
Main Methods:
- Functional gene evaluation using biochemical analysis and animal models.
- Development of gene targeting and artificial chromosome strategies.
- Exploration of DNA delivery systems and non-embryonic stem cell applications.
Main Results:
- Facilitated identification of genes linked to various disease pathologies.
- Opened avenues for developing novel genetic therapies for inherited disorders.
- Stimulated discussion on the implications of genomic data for medicine.
Conclusions:
- The explosion of sequence information is revolutionizing gene therapy.
- A multidisciplinary approach is crucial for advancing genome medicine.
- Ethical and social implications must be considered alongside scientific progress.